Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.
Date
2018-07-31
Author
Rifaioğlu, Ahmet Süreyya
Martin, MJ
Atalay, Rengül
Atalay, Mehmet Volkan
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
60
views
0
downloads
Cite This
The identification of interactions between drugs/compounds and their targets is crucial for the development of new drugs. In vitro screening experiments (i.e. bioassays) are frequently used for this purpose; however, experimental approaches are insufficient to explore novel drug-target interactions, mainly because of feasibility problems, as they are labour intensive, costly and time consuming. A computational field known as 'virtual screening' (VS) has emerged in the past decades to aid experimental drug discovery studies by statistically estimating unknown bio-interactions between compounds and biological targets. These methods use the physico-chemical and structural properties of compounds and/or target proteins along with the experimentally verified bio-interaction information to generate predictive models. Lately, sophisticated machine learning techniques are applied in VS to elevate the predictive performance. The objective of this study is to examine and discuss the recent applications of machine learning techniques in VS, including deep learning, which became highly popular after giving rise to epochal developments in the fields of computer vision and natural language processing. The past 3 years have witnessed an unprecedented amount of research studies considering the application of deep learning in biomedicine, including computational drug discovery. In this review, we first describe the main instruments of VS methods, including compound and protein features (i.e. representations and descriptors), frequently used libraries and toolkits for VS, bioactivity databases and gold-standard data sets for system training and benchmarking. We subsequently review recent VS studies with a strong emphasis on deep learning applications. Finally, we discuss the present state of the field, including the current challenges and suggest future directions. We believe that this survey will provide insight to the researchers working in the field of computational drug discovery in terms of comprehending and developing novel bio-prediction methods.
Subject Keywords
Virtual screening
,
Drug-target interactions
,
Ligand-based VS and proteochemometric modelling
,
Machine learning
,
Deep learning
,
Compound and bioactivity databases
,
Gold-standard data sets
URI
https://hdl.handle.net/11511/31299
Journal
Briefings in bioinformatics
DOI
https://doi.org/10.1093/bib/bby061
Collections
Graduate School of Natural and Applied Sciences, Article
Suggestions
OpenMETU
Core
Hnet-DTI: Incorporating heterogeneous information network for drug-target interaction prediction
Özsarı , Gökhan; Rifaioğlu , Ahmet Süreyya; Doğan , Tunca; Atalay, Volkan (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10)
Identifying drug-target interactions (DTIs) is crucial in drug discovery. In silico prediction of interactions between drugs and target proteins is needed to accelerate the drug discovery process. Although many DTI prediction methods have been proposed in recent years, there is still room for improvement. This study proposes a graph neural network-based method to exploit the heterogeneous information network for drug-target interaction prediction. The study includes two major contributions: Heterogeneous in...
MDeePred: Novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery
Rifaioglu, A.S.; Atalay, R. Cetin; Kahraman, Deniz Cansen; DOĞAN, TUNCA; Martin, M.; Atalay, Mehmet Volkan (2021-03-01)
Motivation: Identification of interactions between bioactive small molecules and target proteins is crucial for novel drug discovery, drug repurposing and uncovering off-target effects. Due to the tremendous size of the chemical space, experimental bioactivity screening efforts require the aid of computational approaches. Although deep learning models have been successful in predicting bioactive compounds, effective and comprehensive featurization of proteins, to be given as input to deep neural networks, r...
Predicting the binding affinities of drug-protein interaction by analyzing the images of binding sites
Erdaş, Özlem; Alpaslan, Ferda Nur; Büyükbingöl, Erdem; Department of Computer Engineering (2013)
Analysis of protein-ligand interactions plays an important role in designing safe and efficient drugs, contributing to drug discovery and development. Recently, machine learning methods have been found useful in drug design, which utilize intelligent techniques to predict unknown protein-ligand interactions by learning from specific properties of known protein-ligand interactions. The aim of this thesis is to propose a novel computational model, Compressed Images for Affinity Prediction (CIFAP), to predict ...
DEEPScreen: high performance drug-target interaction prediction with convolutional neural networks using 2-D structural compound representations
Rifaioğlu, Ahmet Süreyya; Nalbat, Esra; Atalay, Mehmet Volkan (2020-03-07)
The identification of physical interactions between drug candidate compounds and target biomolecules is an important process in drug discovery. Since conventional screening procedures are expensive and time consuming, computational approaches are employed to provide aid by automatically predicting novel drug-target interactions (DTIs). In this study, we propose a large-scale DTI prediction system, DEEPScreen, for early stage drug discovery, using deep convolutional neural networks. One of the main advantage...
In-Depth Method for the Characterization of Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs
Song, Ting; Özcan Kabasakal, Süreyya; Becker, Alicia; Lebrilla, Carlito B. (American Chemical Society (ACS), 2014-06-17)
The glycosylation in recombinant monoclonal antibody (rMab) drugs is a major concern in the biopharmaceutical industry as it impacts the drugs' many attributes. Characterization is important but complicated by the intricate structures, microheterogeneity, and the limitations of current tools for structural analysis. In this study, we developed a liquid chromatography-mass spectrometry (LC-MS) N-glycan library based on eight commercial rMab drugs. A library of over 70 structures was developed for the rapid c...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
A. S. Rifaioğlu, M. Martin, R. Atalay, and M. V. Atalay, “Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.,”
Briefings in bioinformatics
, 2018, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/31299.